Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 7.8% beneficial ownership stake in Kura Oncology Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 6.2% beneficial ownership stake in LendingTree Inc. as of March 31, 2025, held for passive investment purposes.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.2% beneficial ownership stake in MasterCraft Boat Holdings Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, revealing a 6.3% beneficial ownership stake in Match Group, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.3% passive beneficial ownership stake in Nextdoor Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 12 to its Schedule 13G, disclosing a 7.6% beneficial ownership stake in Nu Skin Enterprises Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.7% Stake in OneMain Holdings, Inc. via Amended Schedule 13G Filing
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.7% beneficial ownership stake in OneMain Holdings, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.7% beneficial ownership stake in Pacific Biosciences of California, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, reaffirming its passive beneficial ownership of 8.1% of PagerDuty, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.0% beneficial ownership stake in Phreesia, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 2 to its Schedule 13G, reporting a 6.6% beneficial ownership stake in PlayAGS Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.9% Passive Stake in Pure Storage, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 9.9% passive beneficial ownership stake in Pure Storage, Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, disclosing a 7.2% beneficial ownership stake in RE/MAX Holdings, Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.2% Passive Stake in Sage Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.2% passive beneficial ownership stake in Sage Therapeutics Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.5% Passive Stake in TPG RE Finance Trust, Inc. via Latest SEC Filing
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, reporting a 6.5% beneficial ownership stake in TPG RE Finance Trust, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a beneficial ownership of 8.8% in Tenet Healthcare Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reporting a 13.3% beneficial ownership stake in Teradata Corporation as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.0% Stake in Alcoa Corporation
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 9.0% beneficial ownership stake in Alcoa Corporation as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.9% Stake in Allient Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 5.9% of Allient Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 8.7% of ATI INC's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.4% Stake in Arcellx, Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.4% of Arcellx, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.4% Passive Stake in Arcus Biosciences
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.4% passive beneficial ownership stake in Arcus Biosciences Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.5% Stake in Beam Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.5% in Beam Therapeutics Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 8.3% in Beazer Homes USA Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.7% Stake in Chewy, Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 5.7% of Chewy, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a 6.7% beneficial ownership stake in Coursera, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has reported a 12.2% beneficial ownership stake in Dream Finders Homes, Inc.'s Class A Stock as of March 31, 2025, held for investment purposes.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in First Interstate Bancsystem, Reports 6.3% Passive Ownership
BlackRock, Inc. has filed an Amendment No. 9 to its Schedule 13G, disclosing a 6.3% beneficial ownership stake in First Interstate Bancsystem Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, disclosing a 7.6% beneficial ownership stake in Fortive Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Schedule 13G, Disclosing 7.8% Passive Stake in Fox Corp Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.8% beneficial ownership of Fox Corp's Class A Stock as of March 31, 2025.